Search

Your search keyword '"Benzing, C."' showing total 225 results
Start Over Author "Benzing, C."
225 results on '"Benzing, C."'

2. Outcome after resection for perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis: an international multicentre study

Author

Andreou, A., Bartsch, F., Benzing, C., Buettner, S., Capobianco, I., Charco, R., de Reuver, P.R., de Savornin Lohman, E., Dejong, C.H.C., Efanov, M., Erdmann, J.I., Franken, L.C., Giglio, M.C., Gomez-Gavara, C., Hagendoorn, J., Heid, F., IJzermans, J.N.M., Kazemier, G., Maithel, S.K., Malago, M., Malik, H.Z., Molenaar, Q.I., Muiesan, P., Nooijen, L.E., Nota, C.L.M., Olde Damink, S.W.M., Pratschke, J., Quinn, L.M., Ratti, F., Ravaioli, M., Roberts, K.J., Rolinger, J., Ruzzenente, A., Schadde, E., Schmelzle, M., Serenari, M., Sultana, A., van Laarhoven, S., van Vugt, J.L.A., Zonderhuis, B.M., Jansson, Hannes, Olthof, Pim B., Bergquist, Annika, Ligthart, Marjolein A.P., Nadalin, Silvio, Troisi, Roberto I., Groot Koerkamp, Bas, Alikhanov, Ruslan, Lang, Hauke, Guglielmi, Alfredo, Cescon, Matteo, Jarnagin, William R., Aldrighetti, Luca, van Gulik, Thomas M., and Sparrelid, Ernesto

Published
2021
Full Text
View/download PDF

8. Surgery for Bismuth-Corlette Type 4 Perihilar Cholangiocarcinoma: Results from a Western Multicenter Collaborative Group

Author

Ruzzenente, Andrea, Bagante, Fabio, Olthof, Pim B, Aldrighetti, Luca, Alikhanov, Ruslan, Cescon, Matteo, Koerkamp, Bas Groot, Jarnagin, William R, Nadalin, Silvio, Pratschke, Johann, Schmelzle, Moritz, Sparrelid, Ernesto, Lang, Hauke, Iacono, Calogero, van Gulik, Thomas M, Guglielmi, Alfredo, Andreou A, Bartsch F, Benzing C, Buettner S, Campagnaro T, Capobianco I, Charco R, de Reuver P, de Savornin, Lohman E, Nijmegen, Dejong CHC, Efanov M, Erdmann JI, Franken LC, Giovinazzo G, Giglio MC, Gomez-Gavara C, Heid F, IJzermans JNM, Isaac J, Jansson H, Ligthart MAP, Maithel SK, Malago` M. Malik HZ, Muiesan P, Olde Damink SWM, Quinn LM, Ratti F, Ravaioli M, Rolinger J, Schadde E, Serenari M, Troisi R, van Laarhoven S, van Vugt JLA, Faculteit Medische Wetenschappen/UMCG, Surgery, Ruzzenente, Andrea, Bagante, Fabio, Olthof, Pim B, Aldrighetti, Luca, Alikhanov, Ruslan, Cescon, Matteo, Koerkamp, Bas Groot, Jarnagin, William R, Nadalin, Silvio, Pratschke, Johann, Schmelzle, Moritz, Sparrelid, Ernesto, Lang, Hauke, Iacono, Calogero, van Gulik, Thomas M, Guglielmi, Alfredo, Andreou, A, Bartsch, F, Benzing, C, Buettner, S, Campagnaro, T, Capobianco, I, Charco, R, de Reuver, P, De, Savornin, Lohman, E, Nijmegen, Dejong, Chc, Efanov, M, Erdmann, Ji, Franken, Lc, Giovinazzo, G, Giglio, Mc, Gomez-Gavara, C, Heid, F, Ijzermans, Jnm, Isaac, J, Jansson, H, Ligthart, Map, Maithel, Sk, Malago` M., Malik HZ, Muiesan, P, Olde Damink, Swm, Quinn, Lm, Ratti, F, Ravaioli, M, Rolinger, J, Schadde, E, Serenari, M, Troisi, R, van Laarhoven, S, van Vugt, Jla, Ruzzenente, A., Bagante, F., Olthof, P. B., Aldrighetti, L., Alikhanov, R., Cescon, M., Koerkamp, B. G., Jarnagin, W. R., Nadalin, S., Pratschke, J., Schmelzle, M., Sparrelid, E., Lang, H., Iacono, C., van Gulik, T. M., Guglielmi, A., Andreou, A., Bartsch, F., Benzing, C., Buettner, S., Campagnaro, T., Capobianco, I., Charco, R., de Reuver, P., de Savornin Lohman, E., Dejong, C. H. C., Efanov, M., Erdmann, J. I., Franken, L. C., Giovinazzo, G., Giglio, M. C., Gomez-Gavara, C., Heid, F., Ijzermans, J. N. M., Isaac, J., Jansson, H., Ligthart, M. A. P., Maithel, S. K., Malago, M., Malik, H. Z., Muiesan, P., Damink, S. W. M. O., Quinn, L. M., Ratti, F., Ravaioli, M., Rolinger, J., Schadde, E., Serenari, M., Troisi, R., van Laarhoven, S., van Vugt, J. L. A., CCA - Cancer Treatment and Quality of Life, and AGEM - Amsterdam Gastroenterology Endocrinology Metabolism

Subjects
medicine.medical_specialty, medicine.medical_treatment, Perineural invasion, Metastasis, Cholangiocarcinoma, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], Surgical oncology, Medicine, Hepatectomy, Humans, Perihilar Cholangiocarcinoma, Contraindication, Retrospective Studies, business.industry, Incidence (epidemiology), medicine.disease, Surgery, Oncology, Bile Duct Neoplasms, Cohort, business, Bismuth, Klatskin Tumor
Abstract

Background Although Bismuth-Corlette (BC) type 4 perihilar cholangiocarcinoma (pCCA) is no longer considered a contraindication for curative surgery, few data are available from Western series to indicate the outcomes for these patients. This study aimed to compare the short- and long-term outcomes for patients with BC type 4 versus BC types 2 and 3 pCCA undergoing surgical resection using a multi-institutional international database. Methods Uni- and multivariable analyses of patients undergoing surgery at 20 Western centers for BC types 2 and 3 pCCA and BC type 4 pCCA. Results Among 1138 pCCA patients included in the study, 826 (73%) had BC type 2 or 3 disease and 312 (27%) had type 4 disease. The two groups demonstrated significant differences in terms of clinicopathologic characteristics (i.e., portal vein embolization, extended hepatectomy, and positive margin). The incidence of severe complications was 46% for the BC types 2 and 3 patients and 51% for the BC type 4 patients (p = 0.1). Moreover, the 90-day mortality was 13% for the BC types 2 and 3 patients and 12% for the BC type 4 patients (p = 0.57). Lymph-node metastasis (N1; hazard-ratio [HR], 1.62), positive margins (R1; HR, 1.36), perineural invasion (HR, 1.53), and poor grade of differentiation (HR, 1.25) were predictors of survival (all p ≤0.004), but BC type was not associated with prognosis. Among the N0 and R0 patients, the 5-year overall survival was 43% for the patients with BC types 2 and 3 pCCA and 41% for those with BC type 4 pCCA (p = 0.60). Conclusions In this analysis of a large Western multi-institutional cohort, resection was shown to be an acceptable curative treatment option for selected patients with BC type 4 pCCA although a more technically challenging surgical approach was required.

Published
2020

10. COVID-19 pandemic: implications on the surgical treatment of gastrointestinal and hepatopancreatobiliary tumours in Europe

Author

Nevermann, N F, Hillebrandt, K H, Knitter, S, Ritschl, P V, Krenzien, F, Benzing, C, Bahra, M, Biebl, M, Sauer, I M, Öllinger, R, Schöning, W, Schmelzle, M, Pratschke, J, Abu Hilal, Mohammad, Aldrighetti, Luca, Andersson, Roland, András, Vereczkei, Andreou, Andreas, Arer, İlker Murat, Atıcı, Ali Emre, Szijártó, Attila, Ayav, Ahmet, Aydın, Hüseyin Onur, Bartsch, Detlev, Belli, Andrea, Bertrand, Claude, Bockhorn, Maximilian, Bolli, Martin, Brekalo, Zdrinko, Bruns, Christiane, Ciria, Ruben, Coker, Ahmet, Croner, Roland, dHoore, Andre, Demartines, Nicolas, Demir, Ekin, Dibra, Arvin, Dilek, Osman Nuri, Dogrul, Ahmet, Efanov, Mikhail, Ekmekcigil, Ela, Ergün, Sefa, Farsi, Marco, Fichtner-Feigl, Stefan, Fretland, Åsmund, Friess, Helmut, Beets, Geerard, Gloor, Beat, Gockel, Ines, Gökakın, Ali Kağan, Gomez i Gavara, Concepción, Gretschel, Stephan, Hackl, Christina, Hecker, Andreas, Heinrich, Stefan, Huber, Tobias, Ibis, Cem, Izbicki, Jakob R, Kahlert, Christoph, Kamphues, Carsten, Kapan, Selin, Kazemier, Geert, Kleeff, Joerg, Klink, Christian, Knoefel, Wolfram, Kosieradzki, Maciej, Kube, Rainer, Löb, Stefan, Maagaard Andersen, Lars, Matthaei, Hanno, Mittler, Jens, Morgul, Mehmet Haluk, Moszkowicz, David, Musanovic, Nermin, Nickel, Felix, Nilsson, Magnus, Öfner, Dietmar, Oruğ, Taner, Pascher, Andreas, Pessaux, Patrick, Radionov, Michail, Raraty, Michael, Reissfelder, Christoph, Rhaiem, Rami, Rotellar, Fernando, Ryska, Miroslav, López-Ben, Santiago, Saribeyoglu, Kaya, Schafmayer, Clemens, Schmelzle, Moritz, Schmidt, Thomas, Schneider, Martin, Schoenberg, Markus, Schöning, Wenzel, Seehofer, Daniel, Sönmez, Recep Erçin, Soubrane, Olivier, Stange, Daniel, Strücker, Benjamin, Tursunovic, Amir, Tüzüner, Acar, Vondran, Florian, Weber, Georg, Wellner, Ulrich, Yazici, Pinar, Yeğen, Cumhur, Yol, Sinan, Institut de Recherche sur les Maladies Virales et Hépatiques (IVH), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), COVID‐19 Surgical Oncology Collaboration Group, Nevermann, N. F., Hillebrandt, K. H., Knitter, S., Ritschl, P. V., Krenzien, F., Benzing, C., Bahra, M., Biebl, M., Sauer, I. M., Ollinger, R., Schoning, W., Schmelzle, M., Pratschke, J., Abu Hilal, M., Aldrighetti, L., Andersson, R., Andras, V., Andreou, A., Arer, I. M., Atici, A. E., Szijarto, A., Ayav, A., Aydin, H. O., Bartsch, D., Belli, A., Bertrand, C., Bockhorn, M., Bolli, M., Brekalo, Z., Bruns, C., Ciria, R., Coker, A., Croner, R., D'Hoore, A., Demartines, N., Demir, E., Dibra, A., Dilek, O. N., Dogrul, A., Efanov, M., Ekmekcigil, E., Ergun, S., Farsi, M., Fichtner-Feigl, S., Fretland, A., Friess, H., Beets, G., Gloor, B., Gockel, I., Gokakin, A. K., Gomez i Gavara, C., Gretschel, S., Hackl, C., Hecker, A., Heinrich, S., Huber, T., Ibis, C., Izbicki, J. R., Kahlert, C., Kamphues, C., Kapan, S., Kazemier, G., Kleeff, J., Klink, C., Knoefel, W., Kosieradzki, M., Kube, R., Lob, S., Maagaard Andersen, L., Matthaei, H., Mittler, J., Morgul, M. H., Moszkowicz, D., Musanovic, N., Nickel, F., Nilsson, M., Ofner, D., Orug, T., Pascher, A., Pessaux, P., Radionov, M., Raraty, M., Reissfelder, C., Rhaiem, R., Rotellar, F., Ryska, M., Lopez-Ben, S., Saribeyoglu, K., Schafmayer, C., Schmidt, T., Schneider, M., Schoenberg, M., Seehofer, D., Sonmez, R. E., Soubrane, O., Stange, D., Strucker, B., Tursunovic, A., Tuzuner, A., Vondran, F., Weber, G., Wellner, U., Yazici, P., Yegen, C., Yol, S., UCL - SSS/IREC/MONT - Pôle Mont Godinne, and UCL - (MGD) Service de chirurgie

Subjects
medicine.medical_specialty, 2019-20 coronavirus outbreak, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Pneumonia, Viral, MEDLINE, Surveys and Questionnaires, Correspondence, Pandemic, Humans, Medicine, General, Surgical treatment, Intensive care medicine, Referral and Consultation, Pandemics, Gastrointestinal Neoplasms, SARS-CoV-2, business.industry, Liver Neoplasms, COVID-19, Liver Transplantation, Europe, Pancreatic Neoplasms, Biliary Tract Neoplasms, Surgical Oncology, Italy, Surgical Procedures, Operative, Surgery, Coronavirus Infections, business, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Published
2020
Full Text
View/download PDF

12. Outcome after resection for perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis: an international multicentre study

Author

Jansson, Hannes, primary, Olthof, Pim B., additional, Bergquist, Annika, additional, Ligthart, Marjolein A.P., additional, Nadalin, Silvio, additional, Troisi, Roberto I., additional, Groot Koerkamp, Bas, additional, Alikhanov, Ruslan, additional, Lang, Hauke, additional, Guglielmi, Alfredo, additional, Cescon, Matteo, additional, Jarnagin, William R., additional, Aldrighetti, Luca, additional, van Gulik, Thomas M., additional, Sparrelid, Ernesto, additional, Andreou, A., additional, Bartsch, F., additional, Benzing, C., additional, Buettner, S., additional, Capobianco, I., additional, Charco, R., additional, de Reuver, P.R., additional, de Savornin Lohman, E., additional, Dejong, C.H.C., additional, Efanov, M., additional, Erdmann, J.I., additional, Franken, L.C., additional, Giglio, M.C., additional, Gomez-Gavara, C., additional, Hagendoorn, J., additional, Heid, F., additional, IJzermans, J.N.M., additional, Kazemier, G., additional, Maithel, S.K., additional, Malago, M., additional, Malik, H.Z., additional, Molenaar, Q.I., additional, Muiesan, P., additional, Nooijen, L.E., additional, Nota, C.L.M., additional, Olde Damink, S.W.M., additional, Pratschke, J., additional, Quinn, L.M., additional, Ratti, F., additional, Ravaioli, M., additional, Roberts, K.J., additional, Rolinger, J., additional, Ruzzenente, A., additional, Schadde, E., additional, Schmelzle, M., additional, Serenari, M., additional, Sultana, A., additional, van Laarhoven, S., additional, van Vugt, J.L.A., additional, and Zonderhuis, B.M., additional

Published
2021
Full Text
View/download PDF

17. ASO Visual Abstract

Author

Ruzzenente, A., Bagante, F., Olthof, P.B., Aldrighetti, L., Alikhanov, R., Cescon, M., Koerkamp, B.G., Jarnagin, W.R., Nadalin, S., Pratschke, J., Schmelzle, M., Sparrelid, E., Lang, H., Iacono, C., van Gulik, T.M., Guglielmi, A., Andreou, A., Bartsch, F., Benzing, C., Buettner, S., Campagnaro, T., Capobianco, I., Charco, R., de Reuver, P., de Savornin Lohman, E., Dejong, C.H.C., Efanov, M., Erdmann, J.I., Franken, L.C., Giovinazzo, G., Giglio, M.C., Gomez-Gavara, C., Heid, F., Ijzermans, J.N.M., Isaac, J., Jansson, H., Ligthart, M.A.P., Maithel, S.K., Malago, M., Malik, H.Z., Muiesan, P., Damink, S.W.M.O., Quinn, L.M., Ratti, F., Ravaioli, M., Rolinger, J., Schadde, E., Serenari, M., Troisi, R., van Laarhoven, S., van Vugt, J.L.A., Surgery, CCA - Cancer Treatment and Quality of Life, and Amsterdam Gastroenterology Endocrinology Metabolism

Subjects
Intrahepatic, medicine.medical_specialty, business.industry, General surgery, MEDLINE, Cholangiocarcinoma, Collaborative group, Settore MED/18 - Chirurgia Generale, Oncology, Bile Duct Neoplasms, Surgical oncology, medicine, Humans, Surgery, Bile Ducts, Perihilar Cholangiocarcinoma, business, Bismuth, Bile Ducts, Intrahepatic, Klatskin Tumor
Published
2021
Full Text
View/download PDF

18. Correction to: Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma (Annals of Surgical Oncology, (2020), 10.1245/s10434-020-08258-3)

Author

Olthof P. B., Aldrighetti L., Alikhanov R., Cescon M., Groot Koerkamp B., Jarnagin W. R., Nadalin S., Pratschke J., Schmelzle M., Sparrelid E., Lang H., Guglielmi A., van Gulik T. M., Andreou A., Bartsch F., Benzing C., Buettner S., Capobianco I., de Reuver P., de Savornin Lohman E., Dejong C. H. C., Efanov M., Erdmann J. I., Franken L. C., Frascaroli G., Giglio M. C., Gomez-Gavara C., Heid F., IJzermans J. N. M., Jansson H., Ligthart M. A. P., Maithel S. K., Malago M., Malik H. Z., Muiesan P., Olde Damink S. W. M., Pando E., Quinn L. M., Ratti F., Roberts K. J., Rolinger J., Ruzzenente A., Schadde E., Serenari M., Sultana A., Troisi R., van Laarhoven S., van Vugt J. L. A., Olthof, P. B., Aldrighetti, L., Alikhanov, R., Cescon, M., Groot Koerkamp, B., Jarnagin, W. R., Nadalin, S., Pratschke, J., Schmelzle, M., Sparrelid, E., Lang, H., Guglielmi, A., van Gulik, T. M., Andreou, A., Bartsch, F., Benzing, C., Buettner, S., Capobianco, I., de Reuver, P., de Savornin Lohman, E., Dejong, C. H. C., Efanov, M., Erdmann, J. I., Franken, L. C., Frascaroli, G., Giglio, M. C., Gomez-Gavara, C., Heid, F., Ijzermans, J. N. M., Jansson, H., Ligthart, M. A. P., Maithel, S. K., Malago, M., Malik, H. Z., Muiesan, P., Olde Damink, S. W. M., Pando, E., Quinn, L. M., Ratti, F., Roberts, K. J., Rolinger, J., Ruzzenente, A., Schadde, E., Serenari, M., Sultana, A., Troisi, R., van Laarhoven, S., and van Vugt, J. L. A.

Abstract

In the original article Moritz Schmelzle’s last name is spelled wrong. It is correct as reflected here.

Published
2020

19. Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma

Author

Olthof, P. B., Aldrighetti, L., Alikhanov, R., Cescon, M., Groot Koerkamp, B., Jarnagin, W. R., Nadalin, S., Pratschke, J., Schmelze, M., Sparrelid, E., Lang, H., Guglielmi, A., van Gulik, T. M., Andreou, A., Bartsch, F., Benzing, C., Buettner, S., Capobianco, I., de Reuver, P., de Savornin Lohman, E., Dejong, C. H. C., Efanov, M., Erdmann, J. I., Franken, L. C., Frascaroli, G., Giglio, M. C., Gomez-Gavara, C., Heid, F., IJzermans, J. N. M., Jansson, H., Ligthart, M. A. P., Maithel, S. K., Malago, M., Malik, H. Z., Muiesan, P., Olde Damink, S. W. M., Pando, E., Quinn, L. M., Ratti, F., Roberts, K. J., Rolinger, J., Ruzzenente, A., Schadde, E., Serenari, M., Sultana, A., Troisi, R., van Laarhoven, S., van Vugt, J. L. A., Surgery, Academic Medical Center, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Olthof, P. B., Aldrighetti, L., Alikhanov, R., Cescon, M., Groot Koerkamp, B., Jarnagin, W. R., Nadalin, S., Pratschke, J., Schmelze, M., Sparrelid, E., Lang, H., Guglielmi, A., van Gulik, T. M., Andreou, A., Bartsch, F., Benzing, C., Buettner, S., Capobianco, I., de Reuver, P., de Savornin Lohman, E., Dejong, C. H. C., Efanov, M., Erdmann, J. I., Franken, L. C., Frascaroli, G., Giglio, M. C., Gomez-Gavara, C., Heid, F., Ijzermans, J. N. M., Jansson, H., Ligthart, M. A. P., Maithel, S. K., Malago, M., Malik, H. Z., Muiesan, P., Olde Damink, S. W. M., Pando, E., Quinn, L. M., Ratti, F., Roberts, K. J., Rolinger, J., Ruzzenente, A., Schadde, E., Serenari, M., Sultana, A., Troisi, R., van Laarhoven, S., and van Vugt, J. L. A.

Subjects
Male, medicine.medical_specialty, medicine.medical_treatment, education, 030230 surgery, Preoperative care, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], 03 medical and health sciences, 0302 clinical medicine, Retrospective Studie, Preoperative Care, medicine, Hepatectomy, Humans, Embolization, Abscess, Bile Duct Neoplasm, Aged, Retrospective Studies, portal vein embolization, portal vein embolisation, Perihilar cholangiocarcinoma, Portal Vein, business.industry, Incidence (epidemiology), Liver Neoplasms, Correction, Retrospective cohort study, Middle Aged, Jaundice, medicine.disease, Embolization, Therapeutic, Surgery, Bile Duct Neoplasms, Oncology, Liver Neoplasm, Hepatobiliary Tumors, 030220 oncology & carcinogenesis, Propensity score matching, Cohort, medicine.symptom, business, Liver Failure, Human, Klatskin Tumor
Abstract

Background Preoperative portal vein embolization (PVE) is frequently used to improve future liver remnant volume (FLRV) and to reduce the risk of liver failure after major liver resection. Objective This paper aimed to assess postoperative outcomes after PVE and resection for suspected perihilar cholangiocarcinoma (PHC) in an international, multicentric cohort. Methods Patients undergoing resection for suspected PHC across 20 centers worldwide, from the year 2000, were included. Liver failure, biliary leakage, and hemorrhage were classified according to the respective International Study Group of Liver Surgery criteria. Using propensity scoring, two equal cohorts were generated using matching parameters, i.e. age, sex, American Society of Anesthesiologists classification, jaundice, type of biliary drainage, baseline FLRV, resection type, and portal vein resection. Results A total of 1667 patients were treated for suspected PHC during the study period. In 298 patients who underwent preoperative PVE, the overall incidence of liver failure and 90-day mortality was 27% and 18%, respectively, as opposed to 14% and 12%, respectively, in patients without PVE (p p = 0.005). After propensity score matching, 98 patients were enrolled in each cohort, resulting in similar baseline and operative characteristics. Liver failure was lower in the PVE group (8% vs. 36%, p p p = 0.01), and 90-day mortality (7% vs. 18%, p = 0.03). Conclusion PVE before major liver resection for PHC is associated with a lower incidence of liver failure, biliary leakage, abscess formation, and mortality. These results demonstrate the importance of PVE as an integral component in the surgical treatment of PHC.

Published
2020

23. Correction to: Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma (Annals of Surgical Oncology, (2020), 10.1245/s10434-020-08258-3)

Author

Olthof, P.B. (Pim B.), Aldrighetti, L.A. (L.), Alikhanov, R. (Ruslan), Cescon, M. (Matteo), Groot Koerkamp, B. (Bas), Jarnagin, W.R. (William R.), Nadalin, S. (S.), Pratschke, J. (Johann), Schmelzle, M. (Moritz), Sparrelid, E. (Ernesto), Lang, H. (Hauke), Guglielmi, A. (Alfredo), Gulik, T.M. (Thomas) van, Andreou, A. (A.), Bartsch, F. (F.), Benzing, C. (C.), Büttner, S. (Stefan), Capobianco, I. (I.), Reuver, P.R. (Philip) de, de Savornin Lohman, E. (E.), Dejong, C.H. (Cees), Efanov, M. (M.), Erdmann, J.I. (J. I.), Franken, L.C. (L. C.), Frascaroli, G. (G.), Giglio, M.C. (M. C.), Gomez-Gavara, C. (C.), Heid, F. (F.), IJzermans, J.N.M. (Jan), Jansson, H. (H.), Ligthart, M.A.P. (M. A.P.), Maithel, S.K. (Shishir K.), Malago, M. (M.), Malik, H.Z. (H. Z.), Muiesan, P. (Paolo), Olde Damink, S.W.M. (Steven), Pando, E. (E.), Quinn, L.M. (L. M.), Ratti, F. (F.), Roberts, K.J. (K. J.), Rolinger, J. (J.), Ruzzenente, A. (Andrea), Schadde, E. (E.), Serenari, M. (M.), Sultana, A. (A.), Troisi, R.I., van Laarhoven, S. (S.), Vugt, J.L.A. (Jeroen) van, Olthof, P.B. (Pim B.), Aldrighetti, L.A. (L.), Alikhanov, R. (Ruslan), Cescon, M. (Matteo), Groot Koerkamp, B. (Bas), Jarnagin, W.R. (William R.), Nadalin, S. (S.), Pratschke, J. (Johann), Schmelzle, M. (Moritz), Sparrelid, E. (Ernesto), Lang, H. (Hauke), Guglielmi, A. (Alfredo), Gulik, T.M. (Thomas) van, Andreou, A. (A.), Bartsch, F. (F.), Benzing, C. (C.), Büttner, S. (Stefan), Capobianco, I. (I.), Reuver, P.R. (Philip) de, de Savornin Lohman, E. (E.), Dejong, C.H. (Cees), Efanov, M. (M.), Erdmann, J.I. (J. I.), Franken, L.C. (L. C.), Frascaroli, G. (G.), Giglio, M.C. (M. C.), Gomez-Gavara, C. (C.), Heid, F. (F.), IJzermans, J.N.M. (Jan), Jansson, H. (H.), Ligthart, M.A.P. (M. A.P.), Maithel, S.K. (Shishir K.), Malago, M. (M.), Malik, H.Z. (H. Z.), Muiesan, P. (Paolo), Olde Damink, S.W.M. (Steven), Pando, E. (E.), Quinn, L.M. (L. M.), Ratti, F. (F.), Roberts, K.J. (K. J.), Rolinger, J. (J.), Ruzzenente, A. (Andrea), Schadde, E. (E.), Serenari, M. (M.), Sultana, A. (A.), Troisi, R.I., van Laarhoven, S. (S.), and Vugt, J.L.A. (Jeroen) van

Abstract

In the original article Moritz Schmelzle’s last name is spelled wrong. It is correct as reflected here.

Published
2020
Full Text
View/download PDF

24. Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma

Author

Olthof, P.B. (Pim B.), Aldrighetti, L.A. (L.), Alikhanov, R. (Ruslan), Cescon, M. (Matteo), Groot Koerkamp, B. (Bas), Jarnagin, W.R. (William R.), Nadalin, S. (S.), Pratschke, J. (Johann), Schmelze, M. (Moritz), Sparrelid, E. (Ernesto), Lang, H. (Hauke), Guglielmi, A. (Alfredo), Gulik, T.M. (Thomas) van, Andreou, A. (A.), Bartsch, F. (F.), Benzing, C. (C.), Büttner, S. (Stefan), Capobianco, I. (I.), Reuver, P.R. (Philip) de, de Savornin Lohman, E. (E.), Dejong, C.H.C. (C. H.C.), Efanov, M. (M.), Erdmann, J.I. (Joris), Franken, L.C. (L. C.), Frascaroli, G. (G.), Giglio, M.C. (M. C.), Gomez-Gavara, C. (C.), Heid, F. (F.), IJzermans, J.N.M. (Jan), Jansson, H. (H.), Ligthart, M.A.P. (M. A.P.), Maithel, S.K. (Shishir K.), Malago, M. (M.), Malik, H.Z. (H. Z.), Muiesan, P. (Paolo), Olde Damink, S.W.M. (Steven), Pando, E. (E.), Quinn, L.M. (L. M.), Ratti, F. (F.), Roberts, K.J. (K. J.), Rolinger, J. (J.), Ruzzenente, A. (Andrea), Schadde, E. (E.), Serenari, M. (M.), Sultana, A. (A.), Troisi, R.I., van Laarhoven, S. (S.), Vugt, J.L.A. (Jeroen) van, Olthof, P.B. (Pim B.), Aldrighetti, L.A. (L.), Alikhanov, R. (Ruslan), Cescon, M. (Matteo), Groot Koerkamp, B. (Bas), Jarnagin, W.R. (William R.), Nadalin, S. (S.), Pratschke, J. (Johann), Schmelze, M. (Moritz), Sparrelid, E. (Ernesto), Lang, H. (Hauke), Guglielmi, A. (Alfredo), Gulik, T.M. (Thomas) van, Andreou, A. (A.), Bartsch, F. (F.), Benzing, C. (C.), Büttner, S. (Stefan), Capobianco, I. (I.), Reuver, P.R. (Philip) de, de Savornin Lohman, E. (E.), Dejong, C.H.C. (C. H.C.), Efanov, M. (M.), Erdmann, J.I. (Joris), Franken, L.C. (L. C.), Frascaroli, G. (G.), Giglio, M.C. (M. C.), Gomez-Gavara, C. (C.), Heid, F. (F.), IJzermans, J.N.M. (Jan), Jansson, H. (H.), Ligthart, M.A.P. (M. A.P.), Maithel, S.K. (Shishir K.), Malago, M. (M.), Malik, H.Z. (H. Z.), Muiesan, P. (Paolo), Olde Damink, S.W.M. (Steven), Pando, E. (E.), Quinn, L.M. (L. M.), Ratti, F. (F.), Roberts, K.J. (K. J.), Rolinger, J. (J.), Ruzzenente, A. (Andrea), Schadde, E. (E.), Serenari, M. (M.), Sultana, A. (A.), Troisi, R.I., van Laarhoven, S. (S.), and Vugt, J.L.A. (Jeroen) van

Abstract

Background: Preoperative portal vein embolization (PVE) is frequently used to improve future liver remnant volume (FLRV) and to reduce the risk of liver failure after major liver resection. Objective: This paper aimed to assess postoperative outcomes after PVE and resection for suspected perihilar cholangiocarcinoma (PHC) in an international, multicentric cohort. Methods: Patients undergoing resection for suspected PHC across 20 centers worldwide, from the year 2000, were included. Liver failure, biliary leakage, and hemorrhage were classified according to the respective International Study Group of Liver Surgery criteria. Using propensity scoring, two equal cohorts were generated using matching parameters, i.e. age, sex, American Society of Anesthesiologists classification, jaundice, type of biliary drainage, baseline FLRV, resection type, and portal vein resection. Results: A total of 1667 patients were treated for suspected PHC during the study period. In 298 patients who underwent preoperative PVE, the overall incidence of liver failure and 90-day mortality was 27% and 18%, respectively, as opposed to 14% and 12%, respectively, in patients without PVE (p < 0.001 and p = 0.005). After propensity score matching, 98 patients were enrolled in each cohort, resulting in similar baseline and operative characteristics. Liver failure was lower in the PVE group (8% vs. 36%, p < 0.001), as was biliary leakage (10% vs. 35%, p < 0.01), intra-abdominal abscesses (19% vs. 34%, p = 0.01), and 90-day mortality (7% vs. 18%, p = 0.03). Conclusion: PVE before major liver resection for PHC is associated with a lower incidence of liver failure, biliary leakage, abscess formation, and mortality. These results demonstrate the importance of PVE as an integral component in the surgical treatment of PHC.

Published
2020
Full Text
View/download PDF

25. COVID-19 pandemic: implications on the surgical treatment of gastrointestinal and hepatopancreatobiliary tumours in Europe.

Author

UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - (MGD) Service de chirurgie, Nevermann, N F, Hillebrandt, K H, Knitter, S, Ritschl, P V, Krenzien, F, Benzing, C, Bahra, M, Biebl, M, Sauer, I M, Öllinger, R, Schöning, W, Schmelzle, M, Pratschke, J, COVID-19 Surgical Oncology Collaboration Group, Bertrand, Claude, UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - (MGD) Service de chirurgie, Nevermann, N F, Hillebrandt, K H, Knitter, S, Ritschl, P V, Krenzien, F, Benzing, C, Bahra, M, Biebl, M, Sauer, I M, Öllinger, R, Schöning, W, Schmelzle, M, Pratschke, J, COVID-19 Surgical Oncology Collaboration Group, and Bertrand, Claude

Published
2020

26. Surgery for Bismuth-Corlette Type 4 Perihilar Cholangiocarcinoma: Results from a Western Multicenter Collaborative Group.

Author

Ruzzenente, Andrea, Bagante, Fabio, Olthof, Pim B., Aldrighetti, Luca, Alikhanov, Ruslan, Cescon, Matteo, Koerkamp, Bas Groot, Jarnagin, William R., Nadalin, Silvio, Pratschke, Johann, Schmelzle, Moritz, Sparrelid, Ernesto, Lang, Hauke, Iacono, Calogero, van Gulik, Thomas M., Guglielmi, Alfredo, Perihilar Cholangiocarcinoma Collaboration Group, Andreou, A., Bartsch, F., and Benzing, C.

Abstract

Background: Although Bismuth-Corlette (BC) type 4 perihilar cholangiocarcinoma (pCCA) is no longer considered a contraindication for curative surgery, few data are available from Western series to indicate the outcomes for these patients. This study aimed to compare the short- and long-term outcomes for patients with BC type 4 versus BC types 2 and 3 pCCA undergoing surgical resection using a multi-institutional international database. Methods: Uni- and multivariable analyses of patients undergoing surgery at 20 Western centers for BC types 2 and 3 pCCA and BC type 4 pCCA. Results: Among 1138 pCCA patients included in the study, 826 (73%) had BC type 2 or 3 disease and 312 (27%) had type 4 disease. The two groups demonstrated significant differences in terms of clinicopathologic characteristics (i.e., portal vein embolization, extended hepatectomy, and positive margin). The incidence of severe complications was 46% for the BC types 2 and 3 patients and 51% for the BC type 4 patients (p = 0.1). Moreover, the 90-day mortality was 13% for the BC types 2 and 3 patients and 12% for the BC type 4 patients (p = 0.57). Lymph-node metastasis (N1; hazard-ratio [HR], 1.62), positive margins (R1; HR, 1.36), perineural invasion (HR, 1.53), and poor grade of differentiation (HR, 1.25) were predictors of survival (all p ≤0.004), but BC type was not associated with prognosis. Among the N0 and R0 patients, the 5-year overall survival was 43% for the patients with BC types 2 and 3 pCCA and 41% for those with BC type 4 pCCA (p = 0.60). Conclusions: In this analysis of a large Western multi-institutional cohort, resection was shown to be an acceptable curative treatment option for selected patients with BC type 4 pCCA although a more technically challenging surgical approach was required. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

29. Laparoscopic left lateral liver resection is a safe procedure in cirrhotic patients

Author

Struecker, B., primary, Haber, P., additional, Andreou, A., additional, Raschzok, N., additional, Atanasov, G., additional, Benzing, C., additional, Krenzien, F., additional, Sauer, I., additional, Zorron, R., additional, Biebl, M., additional, Öllinger, R., additional, Bahra, M., additional, Pascher, A., additional, Pratschke, J., additional, and Schmelzle, M., additional

Published
2019
Full Text
View/download PDF

32. Comparison of standard multiport vs. reduced port left lateral liver resection

Author

Struecker, B., primary, Haber, P., additional, Andreou, A., additional, Raschzok, N., additional, Atanasov, G., additional, Benzing, C., additional, Krenzien, F., additional, Sauer, I., additional, Zorron, R., additional, Biebl, M., additional, Öllinger, R., additional, Bahra, M., additional, Pascher, A., additional, Pratschke, J., additional, and Schmelzle, M., additional

Published
2019
Full Text
View/download PDF

36. Humane mesenchymale Stammzellen fördern Regeneration und modulieren metabolische Veränderungen nach partieller Leberregeneration in BALB/c-Mäusen

Author

Wabitsch, S, additional, Benzing, C, additional, Krenzien, F, additional, Splith, K, additional, Haber, PK, additional, Nösser, M, additional, Knitter, S, additional, Kamali, C, additional, Günther, C, additional, Hermann, F, additional, Hirsch, D, additional, Sauer, IM, additional, Pratschke, J, additional, and Schmelzle, M, additional

Published
2018
Full Text
View/download PDF

40. Einfluss der Pankreastransplantation auf das metabolische und kardiale Outcome von Typ I Diabetikern im Langzeitverlauf

Author

Hau, HM, Wiltberger, G, Tautenhahn, HM, Benzing, C, Krenzien, F, Atanasov, G, Schmelzle, M, Uhlmann, D, and Bartels, M

Subjects
ddc: 610, 610 Medical sciences, Medicine
Abstract

Einleitung: Die Effekte der Pankreastransplantation auf die metabolische und kardiale Funktion von Typ1 Diabetikern konnten zwar im Kurzzeitverlauf bestätigt werden, Studien zu Langzeiterfahrungen sind bisher jedoch nur vereinzelt vorhanden. Material und Methoden: Wir analysierten daher klinikopathologische,[zum vollständigen Text gelangen Sie über die oben angegebene URL], 133. Kongress der Deutschen Gesellschaft für Chirurgie

Published
2016
Full Text
View/download PDF

47. Laparoskopische Single-Port Portalvenöse Embolisation vor Trisektorektomie

Author

Wabitsch, S, additional, Haber, P, additional, Benzing, C, additional, Krenzien, F, additional, Andreou, A, additional, Antanasov, G, additional, Strücker, B, additional, Raschzok, N, additional, Gebauer, B, additional, Denecke, T, additional, Zorron, R, additional, Bahra, M, additional, Öllinger, R, additional, Pratschke, J, additional, and Schmelzle, M, additional

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results